| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Aprepitant impurity 19 |
阿瑞匹坦雜質(zhì) |
1242175-36-5 |
詳細
|
| Ketorolac impurity 1/Ketorolac R-Isomer |
酮咯酸雜質(zhì) |
66635-93-6 |
詳細
|
| Darifenacin impurity 2/2,3-Dehydro Darifenacin HBr |
達非那新雜質(zhì) |
943034-52-4 |
詳細
|
| (S)-Ketorolac |
酮咯酸雜質(zhì) |
66635-92-5 |
詳細
|
| Pramipexole impurity 4/Pramipexole EP Impurity D/Dexpramipexole |
普拉克索雜質(zhì) |
104632-28-2 |
詳細
|
| Aprepitant impurity 12 |
阿瑞匹坦雜質(zhì) |
380499-06-9 |
詳細
|
| Lisinopril impurity 2/Lisinopril EP impurity C/S,S,S-Diketopiperazine |
|
328385-86-0 |
詳細
|
| Darifenacin impurity 1/(R)-Darifenacin HBr/ent-Darifenacin HBr |
達非那新雜質(zhì) |
1092800-15-1 |
詳細
|
| Aprepitant impurity 13 |
阿瑞匹坦雜質(zhì) |
1185503-48-3 |
詳細
|
| Pitavastatin impurity 1/(3R, 5R)-Pitavastatin Calcium Salt |
匹伐他汀雜質(zhì) |
254452-96-5 |
詳細
|
| Aprepitant impurity 21/Aprepitant N-Oxide |
阿瑞匹坦雜質(zhì) |
172673-23-3 |
詳細
|
| Orlistat impurity 4/Orlistat USP Related Compound D |
奧利司他雜質(zhì) |
130793-27-0 |
詳細
|
| Aprepitant impurity 17 |
阿瑞匹坦雜質(zhì) |
419574-33-7 |
詳細
|
| Aprepitant impurity 15 |
阿瑞匹坦雜質(zhì) |
327623-37-0 |
詳細
|
| Aprepitant impurity 16 |
阿瑞匹坦雜質(zhì) |
1242175-38-7 |
詳細
|
| Pitavastatin impurity 7/Desfluoro Pitavastatin Calcium Salt |
匹伐他汀雜質(zhì) |
1258947-30-6 |
詳細
|
| Aprepitant impurity 7/(1R,2S,3S)-Aprepitant |
阿瑞匹坦雜質(zhì) |
172822-28-5 |
詳細
|
| Pitavastatin impurity 3/(3S,5S)-Pitavastatin Calcium Salt |
匹伐他汀雜質(zhì) |
254452-92-1 |
詳細
|
| Aprepitant impurity 14 |
阿瑞匹坦雜質(zhì) |
170729-79-0 |
詳細
|
| Pitavastatin Impurity 11 |
匹伐他汀雜質(zhì) |
147511-70-4 |
詳細
|
| Orlistat impurity 5/Orlistat USP Related Compound E/L-Isoleucine Orlistat |
奧利司他雜質(zhì) |
1072902-75-0 |
詳細
|
| Aprepitant impurity 6/(1R,2S,3R)-Aprepitant |
阿瑞匹坦雜質(zhì) |
1185502-97-9 |
詳細
|
| Aprepitant impurity 10/(S,S,S)-Aprepitant |
阿瑞匹坦雜質(zhì) |
1242175-40-1 |
詳細
|
| Aprepitant impurity 18 |
阿瑞匹坦雜質(zhì) |
419574-04-2 |
詳細
|
| Aprepitant impurity 11 |
阿瑞匹坦雜質(zhì) |
1447693-83-5 |
詳細
|
| Aprepitant impurity 8/(1S,2R,3R)-Aprepitant |
阿瑞匹坦雜質(zhì) |
1242175-34-3 |
詳細
|
| Pitavastatin Impurity 9 |
匹伐他汀雜質(zhì) |
148516-15-8 |
詳細
|
| Aprepitant impurity 9/(1S,2R,3S)-Aprepitant |
阿瑞匹坦雜質(zhì) |
170902-81-5 |
詳細
|
| Lisinopril impurity 3/Lisinopril EP Impurity D/R,S,S-Diketopiperazine |
|
219677-82-4 |
詳細
|
| Pitavastatin impurity 2/(3S,5R)-Pitavastatin Calcium Salt |
匹伐他汀雜質(zhì) |
254452-88-5 |
詳細
|
| Mycophenolate Mofetil EP Impurity H/Mycophenolic Lactone/Mycophenolate Sodium EP Impurity A/(RS)-7-Hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydro-furan-5-yl)-ethyl]-3H-isobenzofuranyl-1-one |
霉酚酸嗎啉乙酯雜質(zhì) |
26675-76-3 |
詳細
|
| Aprepitant impurity 1/Aprepitant EP Impurity A /Defluoro Aprepitant |
阿瑞匹坦雜質(zhì) |
170729-76-7 |
詳細
|
| N-tritylethanolamine |
|
24070-16-4 |
詳細
|
| Citalopram impurity 5/Citalopram N-Oxide/Escitalopram EP Impurity H |
|
63284-72-0 |
詳細
|
| Pramipexole impurity 3/Pramipexole EP Impurity B/2-N-Propyl Pramipexole |
普拉克索雜質(zhì) |
1246815-83-7 |
詳細
|
| Aprepitant impurity 5/Aprepitant EP Impurity E |
阿瑞匹坦雜質(zhì) |
1148113-53-4 |
詳細
|
| Mycophenolate Dimethylamide/(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-N,N,4-trimethylhex-4-enamide |
霉酚酸嗎啉乙酯雜質(zhì) |
59058-64-9 |
詳細
|
| Pramipexole impurity 6/Pramipexole Ethylamino Analog/
Ethyl Pramipexole |
普拉克索雜質(zhì) |
1254579-15-1 |
詳細
|
| Pitavastatin impurity 6/(Z)-Pitavastatin Calcium Salt |
匹伐他汀雜質(zhì) |
1159588-21-2 |
詳細
|
| Aprepitant impurity 20/Fosaprepitant Morpholine |
阿瑞匹坦雜質(zhì) |
170902-80-4 |
詳細
|
| Pramipexole impurity 7/Pramipexole N2-Propionyl Impurity |
普拉克索雜質(zhì) |
1801892-43-2 |
詳細
|
| Sivelestat sodium |
西維來司鈉四水合物 |
201677-61-4 |
詳細
|
| Mycophenolate Mofetil EP Impurity D/O-Methyl Mycophenolate Mofetil/2-(Morpholin-4-yl)ethyl (4E)-6-(4,6-dimethoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
霉酚酸嗎啉乙酯雜質(zhì) |
1322681-37-7 |
詳細
|
| Pramipexole impurity 2/Pramipexole Di-Amide |
普拉克索雜質(zhì) |
1346617-47-7 |
詳細
|
| Aprepitant impurity 22/Aprepitant Open-Ring Methyl Ester Impurity |
阿瑞匹坦雜質(zhì) |
219821-37-1 |
詳細
|
| BisphenolA(3-chloro-2-hydroxypropyl)GlycidylEther |
|
13836-48-1 |
詳細
|
| Pitavastatin Impurity 10 |
匹伐他汀雜質(zhì) |
574705-92-3 |
詳細
|
| MirtazapineEPImpurityA |
米氮平雜質(zhì) |
155172-12-6 |
詳細
|
| Orlistat impurity 1/Orlistat Dihydro Pyranone Impurity |
奧利司他雜質(zhì) |
130676-64-1 |
詳細
|
| Aprepitant impurity 4/Aprepitant EP Impurity D/ent-Aprepitant |
阿瑞匹坦雜質(zhì) |
172822-29-6 |
詳細
|
| Quetiapine EP Impurity A |
喹硫平雜質(zhì) |
844639-07-2 |
詳細
|
| Ethyl Mycophenolate/(E)-Ethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate |
霉酚酸嗎啉乙酯雜質(zhì) |
32483-51-5 |
詳細
|
| Mycophenolate Mofetil EP Impurity E/Mycophenolic Acid Methyl Ester/(4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid Methyl Ester |
霉酚酸嗎啉乙酯雜質(zhì) |
31858-66-9 |
詳細
|
| Quetiapine EP Impurity D/
Quetiapine Dimer Impurity/Quetiapine Bis(dibenzothiazepinyl) piperazine Impurity(USP) |
喹硫平雜質(zhì) |
945668-94-0 |
詳細
|
| 2-(6-Chloro-2-methylpyrimidin-4-ylamino)thiazole-5-carboxylic acid ethyl ester |
|
1202357-66-1 |
詳細
|
| Citalopram impurity 4/Citalopram EP Impurity D HCl/(S)-N-Desmethyl Citalopram Hydrochloride |
|
144025-14-9 |
詳細
|
| Lisinopril impurity 4/Lisinopril EP Impurity E/Lisinopril Epimer |
|
85955-59-5 |
詳細
|
| Orlistat impurity 2/Orlistat USP Related Compound A |
奧利司他雜質(zhì) |
104872-06-2 |
詳細
|
| Pramipexole impurity 1/Pramipexole 7-Oxo Impurity |
普拉克索雜質(zhì) |
1286047-33-3 |
詳細
|
| Quetiapine EP Impurity V |
喹硫平雜質(zhì) |
2204369-14-0 |
詳細
|
| Quetiapine EP Impurity P 2HCl |
喹硫平雜質(zhì) |
1011758-03-4 |
詳細
|
| Zolmitriptan EP Impurity C/Zolmitriptan USP Related Compound F/Zolmitriptan Dimer Impurity |
佐米曲普坦雜質(zhì) |
1350928-05-0 |
詳細
|
| Zolmitriptan EP Impurity B/Zolmitriptan N-Oxide/Zolmitriptan USP Related Compound E |
佐米曲普坦雜質(zhì) |
251451-30-6 |
詳細
|
| Mirtazapine EP Impurity B/[2-[(2RS)-4-Methyl-2-phenylpiperazin-1-yl]pyridin-3-yl]methanol |
米氮平雜質(zhì) |
61337-89-1 |
詳細
|
| Quetiapine DBTO Sulfone |
喹硫平雜質(zhì) |
22871-33-6 |
詳細
|
| Quetiapine DBTP 7-Hydroxy Metabolite/7-Hydroxy N-Desalkyl Quetiapine |
喹硫平雜質(zhì) |
232597-73-8 |
詳細
|
| Quetiapine EP Impurity U/Dibenzo[b,f][1,4]thiazepin-11-amine |
喹硫平雜質(zhì) |
5786-26-5 |
詳細
|
| Mycophenolate Mofetil EP Impurity A/O-Desmethyl Mycophenolate Mofetil/2-Morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
霉酚酸嗎啉乙酯雜質(zhì) |
1322681-36-6 |
詳細
|
| Famotidine EP Impurity C HCl |
法莫替丁雜質(zhì) |
76824-17-4 |
詳細
|
| Clavulanate Potassium impurity 1/Potassium Clavulanate EP Impurity A/2,5-Pyrazinediethanol |
克拉維酸鉀雜質(zhì) |
4744-51-8 |
詳細
|
| Quetiapine EP Impurity K |
喹硫平雜質(zhì) |
1371638-10-6 |
詳細
|
| Quetiapine EP Impurity W/O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine |
喹硫平雜質(zhì) |
1800608-95-0 |
詳細
|
| Famotidine EP Impurity B |
法莫替丁雜質(zhì) |
89268-62-2 |
詳細
|
| Mycophenolate Mofetil EP Impurity B/1-(2-Morpholinoethoxy) Mycophenolate Mofetil/2-Morpholinoethyl (E)-6-[1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-1-(2-morpholinoethyl)-3-oxo-5-isobenzofuranyl]-4-methyl-4-hexenoate |
霉酚酸嗎啉乙酯雜質(zhì) |
1094322-91-4 |
詳細
|
| Ramipril EP Impurity C |
雷米普利雜質(zhì) |
99742-35-5 |
詳細
|
| Quetiapine EP Impurity E/Quetiapine bis-Ether |
喹硫平雜質(zhì) |
1371638-05-9 |
詳細
|
| Quetiapine EP Impurity N/Quetiapine Dipiperazine Diether Impurity |
喹硫平雜質(zhì) |
1800291-86-4 |
詳細
|
| Clavulanate Potassium impurity 3/Clavulanate Potassium EP Impurity G |
克拉維酸鉀雜質(zhì) |
374816-32-7 |
詳細
|
| Mycophenolate Mofetil EP Impurity G/Mycophenolate Mofetil N-Oxide/2-(Morpholin-4-yl)ethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoate N-oxide |
霉酚酸嗎啉乙酯雜質(zhì) |
224052-51-1 |
詳細
|
| Pramipexole impurity 8/Pramipexole (7R)-Hydroxy Impurity/Pramipexole USP Related Compound F |
普拉克索雜質(zhì) |
2166216-34-6 |
詳細
|
| Pramipexole impurity 9/Pramipexole (7S)-Hydroxy Impurity/Pramipexole USP Related Compound G |
普拉克索雜質(zhì) |
1001648-71-0 |
詳細
|
| Quetiapine EP Impurity J/Quetiapine Hydroxyethyloxyethyl Ether |
喹硫平雜質(zhì) |
1356906-17-6 |
詳細
|
| Clavulanate Potassium impurity 2/Clavulanate Potassium EP Impurity D |
克拉維酸鉀雜質(zhì) |
404839-11-8 |
詳細
|
| 7-Hydroxy Quetiapine Sulfoxide/Quetiapine Sulfoxide 7-Hydroxy Metabolite |
喹硫平雜質(zhì) |
1185170-04-0 |
詳細
|
| Famotidine EP Impurity F |
法莫替丁雜質(zhì) |
107880-74-0 |
詳細
|
| Quetiapine EP Impurity T/Quetiapine Morpholine Impurity |
喹硫平雜質(zhì) |
5747-46-6 |
詳細
|
| Quetiapine EP Impurity O/O-Triphenylmethoxy Quetiapine |
喹硫平雜質(zhì) |
844639-06-1 |
詳細
|
| Quetiapine EP Impurity H/Quetiapine N-Oxide |
喹硫平雜質(zhì) |
1076199-40-0 |
詳細
|
| Mycophenolic Acid O-Desmethyl Impurity/(4E)-6-(1,3-Dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid |
霉酚酸雜質(zhì) |
31858-65-8 |
詳細
|
| Mirtazapine EP Impurity C/Mirtazapine Lactam/2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one |
米氮平雜質(zhì) |
191546-96-0 |
詳細
|
| Quetiapine EP Impurity I/Quetiapine Hydroxy Impurit |
喹硫平雜質(zhì) |
329216-67-3 |
詳細
|
| Ritonavir EP Impurity H/Des(isopropylthiazolyl) Hydantoin-oxazolidinone Ritonavir |
利托那韋雜質(zhì) |
1010809-43-4 |
詳細
|
| Quetiapine EP Impurity L/9-Chloro Quetiapine |
喹硫平雜質(zhì) |
1371638-11-7 |
詳細
|
| Quetiapine EP Impurity C |
喹硫平雜質(zhì) |
1798840-31-9 |
詳細
|
| Quetiapine EP Impurity S/Quetiapine Sulfoxide |
喹硫平雜質(zhì) |
329216-63-9 |
詳細
|
| Quetiapine EP Impurity F |
喹硫平雜質(zhì) |
848814-27-7 |
詳細
|
| Quetiapine DBTP N-Methyl Impurity |
喹硫平雜質(zhì) |
1977-09-9 |
詳細
|
| Mycophenolic Acid O-Methyl Methyl Ester/O-Methyl Mycophenolic Acid Methyl Ester/Methyl (E)-6-(1,3-dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
霉酚酸雜質(zhì) |
60435-90-7 |
詳細
|
| Famotidine EP Impurity D |
法莫替丁雜質(zhì) |
76824-16-3 |
詳細
|
| Mycophenolic Acid O-Methyl Ether/O-Methyl Mycophenolic Acid/(E)-6-(1,3-Dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid |
霉酚酸雜質(zhì) |
38877-93-9 |
詳細
|